Publication | Open Access
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2.6K
Citations
19
References
2006
Year
As compared with intravenous paclitaxel plus cisplatin, intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel improves survival in patients with optimally debulked stage III ovarian cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1